Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec;71(12):1834-1845.
doi: 10.1002/iub.2157. Epub 2019 Aug 23.

Hsp70 inhibitors: Implications for the treatment of colorectal cancer

Reyhaneh Moradi-Marjaneh  1 , Maryam Paseban  2 , Mahdi Moradi Marjaneh  3
Affiliations
Free article
Review

Hsp70 inhibitors: Implications for the treatment of colorectal cancer

Reyhaneh Moradi-Marjaneh et al. IUBMB Life. 2019 Dec.
Free article

Abstract

Colorectal cancer (CRC) is one of the most common malignancies in the world. Despite intensive advances in diagnosis and treatment of CRC, it is yet one of the leading cause of cancer related morbidity and mortality. Therefore, there is an urgent medical need for alternative therapeutic approaches to treat CRC. The 70 kDa heat shock proteins (Hsp70s) are a family of evolutionary conserved heat shock proteins, which play an important role in cell homeostasis and survival. They overexpress in various types of malignancy including CRC and are typically accompanied with poor prognosis. Hence, inhibition of Hsp70 may be considered as a striking chemotherapeutic avenue. This review summarizes the current knowledge on the progress made so far to discover compounds, which target the Hsp70 family, with particular emphasis on their efficacy in treatment of CRC. We also briefly explain the induction of Hsp70 as a strategy to prevent CRC.

Keywords: Hsp70; cancer; colorectal; inhibitor.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

REFERENCES

    1. Marjaneh RM, Khazaei M, Ferns GA, Avan A, Aghaee-Bakhtiari SH. The role of microRNAs in 5-FU resistance of colorectal cancer: Possible mechanisms. J Cell Physiol. 2019;234(3):2306-2316.
    1. Moradi-Marjaneh R, Hassanian SM, Fiuji H, et al. Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer. J Cell Physiol. 2018;233(8):5613-5622.
    1. Moradi Marjaneh R, Hassanian SM, Ghobadi N, et al. Targeting the death receptor signaling pathway as a potential therapeutic target in the treatment of colorectal cancer. J Cell Physiol. 2018;233(10):6538-6549.
    1. Soleimani A, Zahiri E, Ehtiati S, Norouzi M, Rahmani F, et al. Therapeutic potency of heat-shock protein-70 in the pathogenesis of colorectal cancer, current status and perspectives. Int J Biochem Cell Biol. 2018;97(2):85-90.
    1. Kumar S, Stokes J III, Singh UP, Gunn KS, Acharya A, et al. Targeting Hsp70: A possible therapy for cancer. Cancer Lett. 2016;374(1):156-166.

MeSH terms

LinkOut - more resources